- Home
- EFSC vs HCM Comparison
EFSC vs HCM Comparison
Compare EFSC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- HCM
- Stock Information
- Founded
- EFSC 1988
- HCM 2000
- Country
- EFSC United States
- HCM Hong Kong
- Employees
- EFSC N/A
- HCM N/A
- Industry
- EFSC Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- HCM Health Care
- Exchange
- EFSC Nasdaq
- HCM Nasdaq
- Market Cap
- EFSC 2.1B
- HCM 2.5B
- IPO Year
- EFSC 1999
- HCM N/A
- Fundamental
- Price
- EFSC $55.92
- HCM $17.61
- Analyst Decision
- EFSC Strong Buy
- HCM Buy
- Analyst Count
- EFSC 3
- HCM 2
- Target Price
- EFSC $64.33
- HCM $23.50
- AVG Volume (30 Days)
- EFSC 185.2K
- HCM 56.9K
- Earning Date
- EFSC 07-28-2025
- HCM 08-07-2025
- Dividend Yield
- EFSC 2.15%
- HCM N/A
- EPS Growth
- EFSC 9.23
- HCM N/A
- EPS
- EFSC 5.09
- HCM 0.04
- Revenue
- EFSC $619,222,000.00
- HCM $630,201,000.00
- Revenue This Year
- EFSC $13.90
- HCM $14.86
- Revenue Next Year
- EFSC $4.64
- HCM $19.54
- P/E Ratio
- EFSC $10.96
- HCM $78.60
- Revenue Growth
- EFSC 6.50
- HCM N/A
- 52 Week Low
- EFSC $45.22
- HCM $11.51
- 52 Week High
- EFSC $63.13
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- EFSC 47.27
- HCM 65.30
- Support Level
- EFSC $56.49
- HCM $17.36
- Resistance Level
- EFSC $59.38
- HCM $18.00
- Average True Range (ATR)
- EFSC 1.39
- HCM 0.33
- MACD
- EFSC -0.30
- HCM 0.10
- Stochastic Oscillator
- EFSC 12.63
- HCM 83.12
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.